Literature DB >> 26290394

Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after Parturition.

Tiffany A Katz1, Serena G Liao2, Vincent J Palmieri1, Robert K Dearth3, Thushangi N Pathiraja4, Zhiguang Huo2, Patricia Shaw5, Sarah Small1, Nancy E Davidson1, David G Peters5, George C Tseng2, Steffi Oesterreich6, Adrian V Lee6.   

Abstract

The most effective natural prevention against breast cancer is an early first full-term pregnancy. Understanding how the protective effect is elicited will inform the development of new prevention strategies. To better understand the role of epigenetics in long-term protection, we investigated parity-induced DNA methylation in the mammary gland. FVB mice were bred or remained nulliparous and mammary glands harvested immediately after involution (early) or 6.5 months following involution (late), allowing identification of both transient and persistent changes. Targeted DNA methylation (109 Mb of Ensemble regulatory features) analysis was performed using the SureSelectXT Mouse Methyl-seq assay and massively parallel sequencing. Two hundred sixty-nine genes were hypermethylated and 128 hypomethylated persistently at both the early and late time points. Pathway analysis of the persistently differentially methylated genes revealed Igf1r to be central to one of the top identified signaling networks, and Igf1r itself was one of the most significantly hypermethylated genes. Hypermethylation of Igf1r in the parous mammary gland was associated with a reduction of Igf1r mRNA expression. These data suggest that the IGF pathway is regulated at multiple levels during pregnancy and that its modification might be critical in the protective role of pregnancy. This supports the approach of lowering IGF action for prevention of breast cancer, a concept that is currently being tested clinically. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26290394      PMCID: PMC4677681          DOI: 10.1158/1940-6207.CAPR-15-0178

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  54 in total

1.  Timing of menarche and first full-term birth in relation to breast cancer risk.

Authors:  Christopher I Li; Kathleen E Malone; Janet R Daling; John D Potter; Leslie Bernstein; Polly A Marchbanks; Brian L Strom; Michael S Simon; Michael F Press; Giske Ursin; Ronald T Burkman; Suzanne G Folger; Sandra Norman; Jill A McDonald; Robert Spirtas
Journal:  Am J Epidemiol       Date:  2007-10-26       Impact factor: 4.897

2.  Redefining CpG islands using hidden Markov models.

Authors:  Hao Wu; Brian Caffo; Harris A Jaffee; Rafael A Irizarry; Andrew P Feinberg
Journal:  Biostatistics       Date:  2010-03-08       Impact factor: 5.899

3.  Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.

Authors:  W Ruan; D L Kleinberg
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

4.  Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy.

Authors:  R C Guzman; J Yang; L Rajkumar; G Thordarson; X Chen; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study.

Authors:  Sara J Schonfeld; Ruth M Pfeiffer; James V Lacey; Amy Berrington de González; Michele M Doody; Robert T Greenlee; Yikyung Park; Catherine Schairer; Arthur Schatzkin; Alice J Sigurdson; Patricia Hartge; Kala Visvanathan
Journal:  Am J Epidemiol       Date:  2011-01-25       Impact factor: 4.897

6.  Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis.

Authors:  L Rajkumar; R C Guzman; J Yang; G Thordarson; F Talamantes; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

7.  Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action.

Authors:  Weifeng Ruan; Marie E Monaco; David L Kleinberg
Journal:  Endocrinology       Date:  2004-12-16       Impact factor: 4.736

8.  Defining the genomic signature of the parous breast.

Authors:  Suraj Peri; Ricardo López de Cicco; Julia Santucci-Pereira; Michael Slifker; Eric A Ross; Irma H Russo; Patricia A Russo; Alan A Arslan; Ilana Belitskaya-Lévy; Anne Zeleniuch-Jacquotte; Pal Bordas; Per Lenner; Janet Åhman; Yelena Afanasyeva; Robert Johansson; Fathima Sheriff; Göran Hallmans; Paolo Toniolo; Jose Russo
Journal:  BMC Med Genomics       Date:  2012-10-11       Impact factor: 3.063

9.  Functional DNA methylation differences between tissues, cell types, and across individuals discovered using the M&M algorithm.

Authors:  Bo Zhang; Yan Zhou; Nan Lin; Rebecca F Lowdon; Chibo Hong; Raman P Nagarajan; Jeffrey B Cheng; Daofeng Li; Michael Stevens; Hyung Joo Lee; Xiaoyun Xing; Jia Zhou; Vasavi Sundaram; Ginell Elliott; Junchen Gu; Taoping Shi; Philippe Gascard; Mahvash Sigaroudinia; Thea D Tlsty; Theresa Kadlecek; Arthur Weiss; Henriette O'Geen; Peggy J Farnham; Cécile L Maire; Keith L Ligon; Pamela A F Madden; Angela Tam; Richard Moore; Martin Hirst; Marco A Marra; Baoxue Zhang; Joseph F Costello; Ting Wang
Journal:  Genome Res       Date:  2013-06-26       Impact factor: 9.043

10.  Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.

Authors:  Baljit Singh; Julia A Smith; Deborah M Axelrod; Pietro Ameri; Heather Levitt; Ann Danoff; Martin Lesser; Cristina de Angelis; Irineu Illa-Bochaca; Sara Lubitz; Daniel Huberman; Farbod Darvishian; David L Kleinberg
Journal:  Breast Cancer Res       Date:  2014-11-11       Impact factor: 6.466

View more
  12 in total

1.  FOXA1 Protein Expression in ER+ and ER- Breast Cancer in Relation to Parity and Breastfeeding in Black and White Women.

Authors:  Ting-Yuan David Cheng; Song Yao; Angela R Omilian; Thaer Khoury; Matthew F Buas; Rochelle Payne-Ondracek; Sirinapa Sribenja; Wiam Bshara; Chi-Chen Hong; Elisa V Bandera; Warren Davis; Michael J Higgins; Christine B Ambrosone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-12-23       Impact factor: 4.254

2.  Mitochondrial Genomic Backgrounds Affect Nuclear DNA Methylation and Gene Expression.

Authors:  Carolyn J Vivian; Amanda E Brinker; Stefan Graw; Devin C Koestler; Christophe Legendre; Gerald C Gooden; Bodour Salhia; Danny R Welch
Journal:  Cancer Res       Date:  2017-06-29       Impact factor: 12.701

3.  Impact of vitamin D depletion during development on mouse sperm DNA methylation.

Authors:  Jing Xue; Raad Z Gharaibeh; Edward W Pietryk; Cory Brouwer; Lisa M Tarantino; William Valdar; Folami Y Ideraabdullah
Journal:  Epigenetics       Date:  2018-10-21       Impact factor: 4.528

Review 4.  Relationships between Breast Feeding and Breast Cancer Subtypes: Lessons Learned from Studies in Humans and in Mice.

Authors:  Christine B Ambrosone; Michael J Higgins
Journal:  Cancer Res       Date:  2020-08-14       Impact factor: 12.701

Review 5.  Potential Mechanisms underlying the Protective Effect of Pregnancy against Breast Cancer: A Focus on the IGF Pathway.

Authors:  Tiffany A Katz
Journal:  Front Oncol       Date:  2016-10-26       Impact factor: 6.244

6.  Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study.

Authors:  Mark J Powell; Julie Von Behren; Susan Neuhausen; Peggy Reynolds; Christopher C Benz
Journal:  Cancer Causes Control       Date:  2017-08-18       Impact factor: 2.506

Review 7.  Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk.

Authors:  Genevieve Victoria Dall; Kara Louise Britt
Journal:  Front Oncol       Date:  2017-05-26       Impact factor: 6.244

8.  Environmental Factors Involved in Maternal Morbidity and Mortality.

Authors:  Abee L Boyles; Brandiese E Beverly; Suzanne E Fenton; Chandra L Jackson; Anne Marie Z Jukic; Vicki L Sutherland; Donna D Baird; Gwen W Collman; Darlene Dixon; Kelly K Ferguson; Janet E Hall; Elizabeth M Martin; Thaddeus T Schug; Alexandra J White; Kelly J Chandler
Journal:  J Womens Health (Larchmt)       Date:  2020-11-18       Impact factor: 2.681

9.  Editorial: How Reproductive History Influences Our Breast Cancer Risk.

Authors:  Robin L Anderson; Wendy V Ingman; Kara L Britt
Journal:  Front Oncol       Date:  2017-12-04       Impact factor: 6.244

10.  Pregnancy duration and breast cancer risk.

Authors:  Anders Husby; Jan Wohlfahrt; Nina Øyen; Mads Melbye
Journal:  Nat Commun       Date:  2018-10-23       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.